Responsive image

Common name


9H-fluorene-9-carboxamide

IUPAC name


9H-fluorene-9-carboxamide

SMILES


C1(c2c(cccc2)-c3c1cccc3)C(=O)N

Common name


9H-fluorene-9-carboxamide

IUPAC name


9H-fluorene-9-carboxamide

SMILES


C1(c2c(cccc2)-c3c1cccc3)C(=O)N

INCHI


InChI=1S/C14H11NO/c15-14(16)13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)13/h1-8,13H,(H2,15,16)

FORMULA


C14H11NO

Responsive image

Common name


9H-fluorene-9-carboxamide

IUPAC name


9H-fluorene-9-carboxamide





Molecular weight


209.243

clogP


2.687

clogS


-3.341

Frequency


0.0007





HBond Acceptor


1

HBond Donor


2

Total Polar
Surface Area


43.09

Number of Rings


3

Rotatable Bond


1

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00081 Indecainide Responsive image Anti-Arrhythmia Agents; Sodium Channel Blockers; For the treatment of life-threatening dysrhythmias and sustained ventricular tachycardia.
FDBD01537 Lomitapide Responsive image Hypolipidemic Agents; Lipid Modifying Agents, Plain; Lipid Modifying Agents; Cardiovascular System; CYP3A4 Inhibitors; Used in homozygous familial hypercholesterolemia (HoFH) patients to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C).
2 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
2yki_ligand_1_1.mol2 2yki 0.589744 -8.68 c1cccc2C(c3c(c12)cccc3)NC=O 16
2ykc_ligand_1_0.mol2 2ykc 0.589744 -8.62 c1ccc2c(c1)c1c(C2NC=O)cccc1 16
2ykb_ligand_1_0.mol2 2ykb 0.589744 -8.59 c1ccc2c(c1)c1c(C2NC=O)cccc1 16
2ykj_ligand_1_1.mol2 2ykj 0.589744 -8.58 N(C=O)C1c2ccccc2c2c1cccc2 16
1gmy_ligand_3_83.mol2 1gmy 0.576271 -6.43 c1cc(ccc1)C(C(=O)N)c1ccccc1 16
3f7h_ligand_3_55.mol2 3f7h 0.576271 -6.20 c1(ccccc1)C(c1ccccc1)C(=O)N 16
2woa_ligand.mol2 2woa 0.542169 -9.10 O[C@H](CC(=O)O)CCc1cc2Cc3ccccc3c2cc1 22
4rlk_ligand.mol2 4rlk 0.529412 -10.09 O=C(O)c1ccc(/C=N/N=C2c3ccccc3c3ccccc23)cc1 26
4rll_ligand.mol2 4rll 0.529412 -9.38 O=C(O)c1ccc(/C=N/N=C2c3ccccc3c3ccccc23)cc1 26
107 , 11